Table of contents

Ovarian Cancer

• Interstitial lung disease in patients treated with poly (ADP-ribose) polymerase inhibitors (PARPi): analysis of results from clinical trials and the FDA Adverse Events Reporting System database (10 May, 2023)

  Zhichao He, Jiayao Mo, Wei Jiang, Jianhong Zhu, Shan Yang, Siyuan Gao, Kakei Lam, Yu Li, Kaifeng Qiu, Min Huang, Junyan Wu
• CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer (17 April, 2023)

  Ingrid Boere, Ignace Vergote, Rob Hanssen, Mathilde Jalving, Christine Gennigens, Petronella Ottevanger, Yes J van de Wouw, Cristianne J F Rijcken, Ron H J Mathijssen, Jonathan Ledermann
• Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study (18 April, 2023)

  Robert D Morgan, Andrew R Clamp, Bethany M Barnes, Kirsten Timms, Helene Schlecht, Laura Yarram-Smith, Yvonne Wallis, Mikel Valganon-Petrizan, Suzanne MacMahon, Rhian White, Sian Morgan, Sarah McKenna, Emma Hudson, Laura Tookman, Angela George, Ranjit Manchanda, Sudha S Sundar, Shibani Nicum, James D Brenton, Rebecca S Kristeleit, Susana Banerjee, Iain A McNeish, Jonathan A Ledermann, Stephen S Taylor, D Gareth R Evans, Gordon C Jayson
• BRCA1/2 testing rates in epithelial ovarian cancer: a focus on the untested patients

  (3 May, 2023)

  Lieke Lanjouw, Marian J E Mourits, Joost Bart, Arja ter Elst, Lieke P V Berger, Annemieke H van der Hout, Naufil Alam, Geertruida H de Bock
• Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma (10 July, 2023)

  Anna Myriam Perrone, Camelia Alexandra Coada, Gloria Ravegnini, Antonio De Leo, Giuseppe Damiano, Eugenia De Crescenzo, Marco Tesei, Stella Di Costanzo, Lucia Genovesi, Daniela Rubino, Claudio Zamagni, Pierandrea De Iaco
• Prospective evaluation of an enhanced recovery after surgery (ERAS) pathway in a Norwegian cohort of patients with suspected or advanced ovarian cancer (14 July, 2023)

  Kristina Lindemann, Andreas Kleppe, Brynhildur Eyjólfsdóttir, Svana Heimisdottir Danbolt, Yun Yong Wang, Anne Gjertine Heli-Haugestøl, Sara L Walcott, Odd Mjåland, Gerd-Anita Navestad, Silje Hermanrud, Knut Erling Juul-Hansen, Ulf Kongsgaard